{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-18",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-18.json",
  "legislation": "uksi/2010/1614",
  "legislation_title": "The General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010",
  "path": "schedule/paragraph/18",
  "kind": "paragraph",
  "number": "18",
  "heading": "Decision of the Committee",
  "text": "(1) The written statement under article 40(8) of the Order, must be given, in addition to the appellant, to—\n(a) the case officer; and\n(b) any other person whom the secretary considers, in the public interest, ought to be informed of the Committee’s decision.\n(2) The written statement given to the appellant must be accompanied by a record of any rulings on questions of law or admissibility of evidence made by the chair or the Committee.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 18 in force at 27.9.2010, see rule 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1614/schedule/paragraph/18",
    "retrieved_at": "2026-10-29T02:38:45.129905+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}